Epigenomics AG
EPGNF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | -$4,464 | -$12,024 | -$2,428 |
| Dep. & Amort. | – | $563 | $749 | $419 |
| Deferred Tax | – | $0 | -$59 | -$1,310 |
| Stock-Based Comp. | – | $0 | -$35 | $98 |
| Change in WC | – | -$345 | -$705 | -$988 |
| Other Non-Cash | – | -$1,465 | $50 | $57 |
| Operating Cash Flow | – | -$5,711 | -$12,024 | -$4,152 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | -$3 | -$1,365 | -$35 |
| Net Acquisitions | – | $0 | $0 | $0 |
| Inv. Purchases | – | $0 | $0 | $0 |
| Inv. Sales/Matur. | – | $0 | $0 | $984 |
| Other Inv. Act. | – | $71 | -$335 | $12 |
| Investing Cash Flow | – | $68 | -$1,700 | $961 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | $0 | -$18 | $19,802 |
| Stock Issued | – | $0 | $0 | $2,168 |
| Stock Repurch. | – | -$45 | $0 | -$79 |
| Dividends Paid | – | $0 | $0 | $0 |
| Other Fin. Act. | – | -$57 | -$341 | -$272 |
| Financing Cash Flow | – | -$57 | -$359 | $21,619 |
| Forex Effect | – | $0 | $1,160 | $1,055 |
| Net Chg. in Cash | – | -$5,700 | -$12,923 | $19,483 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | $7,804 | $23,049 | $3,566 |
| End Cash | – | $2,104 | $10,126 | $23,049 |
| Free Cash Flow | – | -$5,714 | -$13,389 | -$4,187 |